Company intelligence / Profile preview

Venclose

San Jose, California, United Statesvenclose.com ↗

Ownership: Private
Employees: ~45
Development stage: Commercial

Overview

The Venclose RF Ablation System was developed as a next-generation minimally invasive device to treat chronic venous insufficiency by ablating diseased veins using radiofrequency energy. It streamlines procedural efficiency and can ablate more vein length per procedure compared to previous systems. The system has been commercialized and adopted as a standard-of-care alternative to laser therapy for CVI.[2][3] Clinical results indicate reduced post-operative pain and bruising compared to laser alternatives.[3] Following its acquisition by BD in December 2021, the technology continues under the BD portfolio.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically Radio Frequency ablation system)
Industry: Therapeutic Medical Devices

Partnerships

No major external partnerships disclosed prior to acquisition; post-acquisition integrated into BD's network.

Beyond the preview

Go deeper on Venclose.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venclose.

Explore the full profile